These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24038458)

  • 1. Inverse probability weighting for covariate adjustment in randomized studies.
    Shen C; Li X; Li L
    Stat Med; 2014 Feb; 33(4):555-68. PubMed ID: 24038458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covariate adjustment in randomized clinical trials with missing covariate and outcome data.
    Chang CR; Song Y; Li F; Wang R
    Stat Med; 2023 Sep; 42(22):3919-3935. PubMed ID: 37394874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of inverse probability weighting using the propensity score for baseline covariate adjustment in smaller population randomised controlled trials with a continuous outcome.
    Raad H; Cornelius V; Chan S; Williamson E; Cro S
    BMC Med Res Methodol; 2020 Mar; 20(1):70. PubMed ID: 32293286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data.
    Xie J; Liu C
    Stat Med; 2005 Oct; 24(20):3089-110. PubMed ID: 16189810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the covariate-adjusted estimation for an overall treatment difference with data from a randomized comparative clinical trial.
    Tian L; Cai T; Zhao L; Wei LJ
    Biostatistics; 2012 Apr; 13(2):256-73. PubMed ID: 22294672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Simulation-Based Comparison of Covariate Adjustment Methods for the Analysis of Randomized Controlled Trials.
    Chaussé P; Liu J; Luta G
    Int J Environ Res Public Health; 2016 Apr; 13(4):414. PubMed ID: 27077870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing the power of the Mann-Whitney test in randomized experiments through flexible covariate adjustment.
    Vermeulen K; Thas O; Vansteelandt S
    Stat Med; 2015 Mar; 34(6):1012-30. PubMed ID: 25475954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variance reduction in randomised trials by inverse probability weighting using the propensity score.
    Williamson EJ; Forbes A; White IR
    Stat Med; 2014 Feb; 33(5):721-37. PubMed ID: 24114884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of covariate adjustment approaches under model misspecification in individually randomized trials.
    Tackney MS; Morris T; White I; Leyrat C; Diaz-Ordaz K; Williamson E
    Trials; 2023 Jan; 24(1):14. PubMed ID: 36609282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improve efficiency and reduce bias of Cox regression models for two-stage randomization designs using auxiliary covariates.
    Yang X; Zhou Y
    Stat Med; 2017 May; 36(11):1683-1695. PubMed ID: 28183157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?
    Karrison T; Kocherginsky M
    Clin Trials; 2018 Apr; 15(2):178-188. PubMed ID: 29502444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-stage matching-adjusted indirect comparison.
    Remiro-Azócar A
    BMC Med Res Methodol; 2022 Aug; 22(1):217. PubMed ID: 35941551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival trial design and monitoring using historical controls.
    Wu J; Xiong X
    Pharm Stat; 2016 Sep; 15(5):405-11. PubMed ID: 27307025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditional estimation and inference to address observed covariate imbalance in randomized clinical trials.
    Zhang Z; Tang L; Liu C; Berger VW
    Clin Trials; 2019 Apr; 16(2):122-131. PubMed ID: 30444129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Irwin's restricted mean as an index for comparing survival in different treatment groups--interpretation and power considerations.
    Karrison TG
    Control Clin Trials; 1997 Apr; 18(2):151-67. PubMed ID: 9129859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Instability of inverse probability weighting methods and a remedy for nonignorable missing data.
    Li P; Qin J; Liu Y
    Biometrics; 2023 Dec; 79(4):3215-3226. PubMed ID: 37221141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model misspecification and robustness in causal inference: comparing matching with doubly robust estimation.
    Waernbaum I
    Stat Med; 2012 Jul; 31(15):1572-81. PubMed ID: 22359267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size calculation for randomized trials via inverse probability of response weighting when outcome data are missing at random.
    Harrison LJ; Wang R
    Stat Med; 2023 May; 42(11):1802-1821. PubMed ID: 36880120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive covariate adjustment in clinical trials.
    Wang SJ; Hung HM
    J Biopharm Stat; 2005; 15(4):605-11. PubMed ID: 16022166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced precision in the analysis of randomized trials with ordinal outcomes.
    Díaz I; Colantuoni E; Rosenblum M
    Biometrics; 2016 Jun; 72(2):422-31. PubMed ID: 26576013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.